
Noodles unveils $120.9 million Q3 revenue
Key points
- Noodles & Company (NASDAQ:NDLS) reported third-quarter 2026 revenue of $120.9 million, while system-wide comparable restaurant sales increased 9.5%.
- Net loss narrowed to $2.1 million from $9.2 million, while adjusted EBITDA increased 34.3% to $8.7 million.
- The company expects 2026 revenue of $485 million–$495 million and adjusted EBITDA of $35 million–$37 million, while continuing its strategic alternatives review.
Noodles & Company (NASDAQ:NDLS) reported third-quarter 2026 revenue of $120.9 million, alongside a 9.5% increase in system-wide comparable restaurant sales.
Comparable sales increased 10.7% at company-owned restaurants and 4.9% at franchised locations, despite the decline in total revenue compared with the previous year.
Net loss narrowed to $2.1 million, or $0.36 per diluted share, from $9.2 million, or $1.58 per share, while operating margin improved to 0.1% from negative 5.2% and adjusted EBITDA increased 34.3% to $8.7 million.
At September 29, 2026, the company had $1.5 million in cash, $101 million in outstanding debt and $21.2 million available under its revolving credit facility, while a November 12 amendment extended the facility's maturity to November 30, 2027.
The company now expects full-year 2026 revenue of $485 million–$495 million and adjusted EBITDA of $35 million–$37 million, compared with its previous guidance of $485 million–$500 million and $34 million–$38 million, respectively.
Noodles & Company continues reviewing strategic alternatives, including refinancing its debt, refranchising operations or selling all or part of the business, as it works to improve its financial position.
Frequently asked questions
More from United States
Zai Lab antibody shows sustained biomarker suppression in phase 1 trial
Sigma Lithium posts $22.3 million gross revenue
Milestone Pharmaceuticals cuts costs 30%, extends runway
Merck gains EU backing after 26% risk reduction
Kolibri Q3 revenue hits $18.3M, up 22%
Merck gains EU backing for 24-month RSV use
